Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing fosamprenavir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fosamprenavir (substance) |
Inferred relationship |
Some |
1 |
Lexiva |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fosamprenavir (substance) |
Inferred relationship |
Some |
|
Product containing precisely fosamprenavir 700 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fosamprenavir (substance) |
Inferred relationship |
Some |
|
Lexiva 700mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fosamprenavir (substance) |
Inferred relationship |
Some |
|
Fosamprenavir calcium (substance) |
Is a |
False |
Fosamprenavir (substance) |
Inferred relationship |
Some |
|
Fosamprenavir (as fosamprenavir calcium) 50 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fosamprenavir (substance) |
Inferred relationship |
Some |
|
Product containing precisely fosamprenavir 700 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fosamprenavir (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fosamprenavir 700 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Fosamprenavir (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely fosamprenavir 700 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Fosamprenavir (substance) |
Inferred relationship |
Some |
1 |
Product containing fosamprenavir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fosamprenavir (substance) |
Inferred relationship |
Some |
1 |
Fosamprenavir (as fosamprenavir calcium) 50 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fosamprenavir (substance) |
Inferred relationship |
Some |
1 |
Fosamprenavir calcium (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Fosamprenavir (substance) |
Inferred relationship |
Some |
|
Product containing only fosamprenavir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fosamprenavir (substance) |
Inferred relationship |
Some |
1 |
Fosamprenavir only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fosamprenavir (substance) |
Inferred relationship |
Some |
1 |
Fosamprenavir (as fosamprenavir calcium) 700 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Fosamprenavir (substance) |
Inferred relationship |
Some |
1 |